MKO Melt is a Sublingual Troche in the Human Prescription Drug category. It is labeled and distributed by Imprimis Njof, Llc. The primary component is Midazolam; Ketamine Hydrochloride; Ondansetron Hydrochloride.
| Product ID | 71384-630_7cdebcbc-03dc-1669-e053-2991aa0a3cd6 |
| NDC | 71384-630 |
| Product Type | Human Prescription Drug |
| Proprietary Name | MKO Melt |
| Generic Name | Midazolaam - Ketamine Hcl - Ondansetron |
| Dosage Form | Troche |
| Route of Administration | SUBLINGUAL |
| Marketing Start Date | 2018-12-01 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | Imprimis NJOF, LLC |
| Substance Name | MIDAZOLAM; KETAMINE HYDROCHLORIDE; ONDANSETRON HYDROCHLORIDE |
| Active Ingredient Strength | 3 mg/1; mg/1; mg/1 |
| Pharm Classes | Benzodiazepine [EPC],Benzodiazepines [CS],General Anesthesia [PE],General Anesthetic [EPC],Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |
| DEA Schedule | CIII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2018-12-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-12-01 |
| Marketing End Date | 2019-03-04 |
| Inactivation Date | 2020-01-31 |
| Reactivation Date | 2020-02-10 |
| Ingredient | Strength |
|---|---|
| MIDAZOLAM | 3 mg/1 |
| SPL SET ID: | 7cdebcbc-03db-1669-e053-2991aa0a3cd6 |
| Manufacturer | |
| UNII |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() MKO MELT 97786334 not registered Live/Pending |
Melt Pharmaceuticals, Inc. 2023-02-08 |
![]() MKO MELT 86966404 5158235 Live/Registered |
MELT PHARMACEUTICALS, INC. 2016-04-06 |